| Testimonials From Related Events |
‘An excellent conference. It was very interactive and I for one certainly learned a lot.’
L Fiori, Clinical Trial Outsourcing & Compliance, Compliance & Quality Management Boehringer Ingelheim USA
‘This is the best event that we’ve been to all year; we had 21 meetings, of which 19 were excellent’
M Mohan, Business Development Manager, Manipal Acunova
‘I had a great time and have had learned a great deal from the meeting. The agenda was very well managed’
S Mong, Vice President, Drug Development –Jiangsu Hengrui Pharmaceuticals
‘Good mix of investigators, sites, pharmas and partners… led to lively discussions, good participation’
R Padbiri, Clinical Study Manager, Asia Pacific, Takeda Clinical Research
‘Thank you organizing an excellent conference such as the “Partnerships in Clinical Trials Asia Pacific”’
P Nandy, Director Clinical & Regulatory, Semler Research Centre
|
|
|
 |
Clinical Trials Japan will be held in Tokyo on 6-8 July 2011. It will bring together experts in clinical development, top clinicians, investigators, heads of Clinical Operations and Clinical Research from global and Japanese pharma companies, medical device companies, biotechs, CROs and research institutes in Japan to discuss best practices, operational excellence and strategies in clinical development, updates in regulatory and compliance and timely issues like addressing a lack of a pool of skilled professionals in Japan and patient recruitment.
| 7 Reasons Why You Should Join Us
This July: |
 |
Resolve cost and speed challenges in conducting trials in Japan |
|
Gain valuable insights, learn best practices and review existing
methodologies from leading regional and global practitioners,
to optimize the clinical development process |
|
Take an in-depth look into Japan’s regulatory and operational
landscape in clinical development |
|
Assess the viability of entering or expanding into the Japan market |
|
Take full advantage of practical learning and detailed how-to’s in
pre-summit workshops from the experts |
|
Ensure the right mechanisms are in place for effective execution of your clinical trials in Japan |
|
Be inspired by and learn from your peers in clinical development, facing the same challenges as you |
| Key Themes And Issues To Be
Discussed Include: |
|
Regulatory Reforms to Support Clinical Development in Japan |
|
Understanding & Addressing Key Challenges in Japanese Trials |
|
Adapting Global Clinical Trial Strategies |
|
Application of Global Best
Practice and Experience |
|
Key Barriers to Optimising Speed & Cost Effectiveness in Japan |
|
Expediting Trials Through Collaboration with External Stakeholders |
|
Future Growth & Opportunities in Clinical Trials in Japan |
| Featuring Industry Case
Studies From: |
|
Dr Hideo Kusuoka, Director General, Osaka National Hospital |
|
E.Stewart Geary, Vice President, Deputy Director of Corporate Regulatory Compliance and Quality Assurance HQ, Eisai Co. Ltd. |
|
Yutaka Natsumeda, Director of Office of Clinical Trials, Yokohama City University Hospital |
|
Yoshinobu Tanaka, Assistant Director-Oncology Group, Clinical Science, Merck |
|
Pabel Delgado, Deputy Group Leader, Strategic Planning, Pharmaceutical Development Division, Shionogi & Co., Ltd |
|
Shinichi Nishiuma, Vice-chairperson, Japanese Association of Pharmaceutical Medicine (JAPhMed), Lead Physician / Senior Medical Advisor, Global Patient Safety Japan, Eli Lilly |
|
Jeroze Dalal, General Manager, Clinical Operations, GlaxoSmithKline |
|
Hiroshi Sugii, Vice President Clinical Development, Novo Nordisk |
|
Tadashi Fujisawa, Chief Executive Officer, Mebiopharm |
|
Dr Shivraj Dasari, Qualified Assessor for Clinical Trials, Ministry of Health, Malaysia, Vice President – Quality Management and Regulatory Affairs, InnoBio Ventures |
|
|
|
| International Marketing Partner |
|
|
